PMID- 29250665 OWN - NLM STAT- MEDLINE DCOM- 20180807 LR - 20180807 IS - 2066-8279 (Electronic) IS - 1220-0522 (Linking) VI - 58 IP - 3 DP - 2017 TI - The correlation between insulin-like growth factor with glycemic control, glomerular filtration rate, blood pressure, hematological changes or body mass index in patients with type 2 diabetes mellitus. PG - 857-861 AB - Insulin-like growth factor (IGF) family is made up of two polypeptides, IGF-I and IGF-II, six specific binding proteins (IGFBPs 1-6) and specific receptors. IGF-I is involved in the regulation of growth and cellular proliferation and has a similar structure to insulin. The major IGF transport function is attributed to IGFBP-3. Some studies have highlighted the association between IGF and diabetes. The aims of this study were to analyze the correlation between IGF with glycemic control, glomerular filtration rate (GFR), blood pressure, hematological changes or body mass index (BMI) in patients with type 2 diabetes mellitus (T2DM). Thirty patients with T2DM and thirty non-diabetic control patients were included in this study. Clinical, anthropometric, biochemical parameters and morphology of blood smear were recorded. Blood pressure was determined by mercury sphygmomanometer. The anthropometric measurement included BMI. The biochemical parameters included fasting plasma glucose (FPG), glycated hemoglobin (HbA1c), GFR, serum IGF-I, IGFBP-3 levels. The IGF-I/IGFBP-3 ratio was evaluated. The plasma glucose was determined enzymatically, HbA1c was determined by high-performance liquid chromatography (HPLC) and GFR was calculated automatically. IGF-I was measured by immunoradiometric assay (ELISA - enzyme-linked immunosorbent assay) and IGFBP-3 by sensitivity immunoassay. For the analysis of the morphology of blood smear, May-Grunwald-Giemsa (MGG) was used as staining technique. The microscopic examination was performed initially with the objectives of 10x/20x and subsequently with an immersion objective of 100x. Image acquisition was done after the examination of the preparations obtained with a 40x objective, using Image Pro Plus 6.0 software. In the present study, we observed that T2DM leads to an increase in the IGF-I and IGFBP-3 levels. No relationship was obtain between IGF-I, IGFBP-3 levels and IGF-I/IGFBP-3 ratio with neither parameters studied. The difference of serum IGF-I and IGFBP-3 levels between patients with T2DM and subjects without diabetes showed that IGF-I may be a useful marker for diabetes mellitus and IGFBP-3 for possible complications of this affection. FAU - NeamTu, Marius Cristian AU - NeamTu MC AD - Department of Sports Medicine and Kinesiology, University of Craiova, Romania; oanacristineamtu@yahoo.com. FAU - Avramescu, Elena Taina AU - Avramescu ET FAU - Marcu, Iulia Rahela AU - Marcu IR FAU - Turcu-Stiolica, Adina AU - Turcu-Stiolica A FAU - Boldeanu, Mihail Virgil AU - Boldeanu MV FAU - NeamTu, Oana Maria AU - NeamTu OM FAU - Tudorache, Stefania AU - Tudorache S FAU - Danciulescu Miulescu, Rucsandra Elena AU - Danciulescu Miulescu RE LA - eng PT - Journal Article PL - Romania TA - Rom J Morphol Embryol JT - Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie JID - 9112454 RN - 0 (Blood Glucose) RN - 0 (IGF1 protein, human) RN - 67763-96-6 (Insulin-Like Growth Factor I) SB - IM MH - Blood Glucose/*metabolism MH - Blood Pressure/*physiology MH - Body Mass Index MH - Diabetes Mellitus, Type 2/*blood/*genetics/pathology MH - Female MH - Glomerular Filtration Rate/*physiology MH - Humans MH - Insulin-Like Growth Factor I/*metabolism MH - Male MH - Middle Aged EDAT- 2017/12/19 06:00 MHDA- 2018/08/08 06:00 CRDT- 2017/12/19 06:00 PHST- 2017/12/19 06:00 [entrez] PHST- 2017/12/19 06:00 [pubmed] PHST- 2018/08/08 06:00 [medline] AID - 580317857861 [pii] PST - ppublish SO - Rom J Morphol Embryol. 2017;58(3):857-861.